Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,551-1,575 of 2,022
CompletedNCT01911676

Translational Neuroscience Optimization of GlyT1 Inhibitor

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 21 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT00878462

An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)

This study exists to learn from real-world information that can show how the medication Unflavored fits into care. Researchers are trying to understand how people respond to the medication Unflavored in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
Global
Sponsor
Organon and Co
Condition
Schizophrenia
CompletedNCT00151424

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
Global
Sponsor
Organon and Co
Condition
Schizophrenia
CompletedNCT00156117

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
Global
Sponsor
Organon and Co
Condition
Schizophrenia
CompletedNCT04673851

Horyzons: Implementation in Clinical Practice

This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
CompletedNCT04748679

Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand what cognitive behavioural therapy, a structured talking treatment, can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
CompletedNCT01006551

Ziprasidone in Early Onset Schizophrenia Spectrum Disorders

This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 6 Years to 19 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
CompletedNCT00212836

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
Global
Sponsor
Organon and Co
Condition
Schizophrenia
CompletedNCT03730831

Childhood Maltreatment, Traumatic Experiences and Stress-associated Parameters in Schizophrenia Spectrum Disorders

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
University of Konstanz
Condition
Schizophrenia
TerminatedNCT03669640

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Japan, Spain, Ukraine, United States
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Not Yet RecruitingNCT06546475

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

This study exists to compare options and see whether the medication Tapering offers something meaningfully different. Researchers are trying to understand whether the medication Tapering can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Global
Sponsor
National Taiwan University Hospital
Condition
Schizophrenia
CompletedNCT03829280

Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM)

This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
Schizophrenia
WithdrawnNCT05870384

Application of Group Interpersonal Psychotherapy (IPT-G) to Family Members Caring for Patients With Schizophrenia

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Abant Izzet Baysal University
Condition
Schizophrenia
CompletedNCT04118127

A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses

This study exists to better understand the safety of the medication Brexpiprazole and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Brexpiprazole in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Schizophrenia
TerminatedNCT04210557

Models of Auditory Hallucination

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT06527885

Lurasidone Non-Interventional Study in Schizophrenia Patients

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 99 Years
Countries
Italy
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Condition
Schizophrenia
Not Yet RecruitingNCT06471179

Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairments

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
Global
Sponsor
Assiut University
Condition
Schizophrenia
CompletedNCT02067975

Tryptophan MRI in People With Schizophrenia and Healthy Controls

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
WithdrawnNCT05389345

tDCS and Executive Function Training for Schizophrenia

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Schizophrenia